Live-attenuated RNA hybrid vaccine technology provides single-dose protection against Chikungunya virus

Emily A. Voigt(Oregon Health & Science University), Neal Van Hoeven(Sana Biotechnology (United States)), Jasmine Fuerte-Stone(Infectious Disease Research Institute), Jacob Archer(Infectious Disease Research Institute), Brian Granger(Infectious Disease Research Institute)
Molecular Therapy
May 29, 2021
Cited by 22


Related Papers